212 related articles for article (PubMed ID: 14535580)
21. Transmission of canine transmissible venereal tumour between two dogs in the UK.
Hayes AM; Schiavo L; Constantino-Casas F; Desmas I; Dobson J; Draper A; Elliot J; Genain MA; Wang J; Murchison EP
J Small Anim Pract; 2023 Sep; 64(9):590-594. PubMed ID: 36990106
[TBL] [Abstract][Full Text] [Related]
22. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of canine transmissible venereal tumour in Grenada, West Indies.
Schectman SJ; Khanam A; Walters MND; Kirwan E; Sylvester WR; Khan FA
Vet Med Sci; 2022 May; 8(3):1008-1012. PubMed ID: 35238497
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
[TBL] [Abstract][Full Text] [Related]
25. Immunocharacterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 in canine transmissible venereal tumors.
Akkoc A; Nak D; Demirer A; Şimşek G
Biotech Histochem; 2017; 92(2):100-106. PubMed ID: 28296543
[TBL] [Abstract][Full Text] [Related]
26. Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcoma.
Yang TJ; Palker TJ; Harding MW
Cancer Immunol Immunother; 1991; 33(4):255-62. PubMed ID: 2059969
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
Mukaratirwa S; Chitanga S; Chimatira T; Makuleke C; Sayi ST; Bhebhe E
J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
[TBL] [Abstract][Full Text] [Related]
28. Sex disparity in oronasal presentations of canine transmissible venereal tumour.
Strakova A; Baez-Ortega A; Wang J; Murchison EP
Vet Rec; 2022 Sep; 191(5):e1794. PubMed ID: 35781651
[TBL] [Abstract][Full Text] [Related]
29. Use of a murine xenograft model for canine transmissible venereal tumor.
Harmelin A; Pinthus JH; Katzir N; Kapon A; Volcani Y; Amariglio EN; Rehavi G
Am J Vet Res; 2001 Jun; 62(6):907-11. PubMed ID: 11400849
[TBL] [Abstract][Full Text] [Related]
30. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
[TBL] [Abstract][Full Text] [Related]
31. Immunoelectron microscopic localization of a tumor-associated antigen (TAA) in the canine transmissible venereal sarcoma by anti-TAA-antiferritin hybrid antibodies.
Hill DL; Yang TJ
J Natl Cancer Inst; 1985 Oct; 75(4):725-32. PubMed ID: 3900513
[TBL] [Abstract][Full Text] [Related]
32. Canine transmissible venereal tumor (TVT): a review.
Vermooten MI
J S Afr Vet Assoc; 1987 Sep; 58(3):147-50. PubMed ID: 3334057
[TBL] [Abstract][Full Text] [Related]
33. Stromal cells and extracellular matrix components in spontaneous canine transmissible venereal tumour at different stages of growth.
Mukaratirwa S; Chimonyo M; Obwolo M; Gruys E; Nederbragt H
Histol Histopathol; 2004 Oct; 19(4):1117-23. PubMed ID: 15375754
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
Kanca H; Tez G; Bal K; Ozen D; Alcigir E; Atalay Vural S
Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
[TBL] [Abstract][Full Text] [Related]
35. The canine transmissible venereal tumor: a unique result of tumor progression.
Cohen D
Adv Cancer Res; 1985; 43():75-112. PubMed ID: 3887857
[No Abstract] [Full Text] [Related]
36. Clinicopathological study of canine transmissible venereal tumour in leishmaniotic dogs.
Marino G; Gaglio G; Zanghì A
J Small Anim Pract; 2012 Jun; 53(6):323-7. PubMed ID: 22489831
[TBL] [Abstract][Full Text] [Related]
37. The changing global distribution and prevalence of canine transmissible venereal tumour.
Strakova A; Murchison EP
BMC Vet Res; 2014 Sep; 10():168. PubMed ID: 25186078
[TBL] [Abstract][Full Text] [Related]
38. Canine transmissible venereal tumour: assessment of mast cell numbers as indicators of the growth phase.
Mukaratirwa S; Chiwome T; Chitanga S; Bhebhe E
Vet Res Commun; 2006 Aug; 30(6):613-21. PubMed ID: 16838203
[TBL] [Abstract][Full Text] [Related]
39. [Growth and regression course of canine transmissible sarcoma transplanted into beagles and mongrel dogs (author's transl)].
Kudo T; Koike T; Otomo K; Sakai T
Nihon Juigaku Zasshi; 1981 Jun; 43(3):421-8. PubMed ID: 7321366
[No Abstract] [Full Text] [Related]
40. A tale of two tumours: comparison of the immune escape strategies of contagious cancers.
Siddle HV; Kaufman J
Mol Immunol; 2013 Sep; 55(2):190-3. PubMed ID: 23200636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]